Direct access to your doctor throughout the protocol for questions, adjustments and check-ins
The Subcutaneous Dosing Reality Now heres where things gets interesting The commonly cited research-use only dosages of 100250 mcg subcutaneously once daily for sleep optimization are based on case reports and observational studies, not on controlled trials that demonstrated the efficacy of DSIP Does this necessarily invalidate the subcutaneous use of DSIP
This is really alarming, said Rita Jew, a pharmacist and president of the Institute for Safe Medication Practices, in an interview ahead of the meeting
occasional reports of mild headache, transient jitteriness, or injection-site reactions
The combination is not clinically validated and these figures come from reference protocols, not approved human dosing
Browse its supplements now